SLC7A2
Basic information
Region (hg38): 8:17497088-17570573
Previous symbols: [ "ATRC2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC7A2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 46 | 54 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 2 | |||||
Total | 0 | 0 | 46 | 3 | 12 |
Variants in SLC7A2
This is a list of pathogenic ClinVar variants found in the SLC7A2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-17538841-G-A | not specified | Uncertain significance (Aug 02, 2021) | ||
8-17538855-G-T | not specified | Uncertain significance (Nov 09, 2024) | ||
8-17538864-A-G | not specified | Uncertain significance (Aug 12, 2021) | ||
8-17538871-G-A | SLC7A2-related disorder | Benign (Nov 01, 2019) | ||
8-17538903-T-G | not specified | Uncertain significance (Oct 12, 2024) | ||
8-17538906-G-C | SLC7A2-related disorder | Benign (Nov 01, 2019) | ||
8-17538911-C-A | not specified | Uncertain significance (Dec 02, 2024) | ||
8-17538930-T-TC | SLC7A2-related disorder | Benign (Nov 26, 2019) | ||
8-17538932-A-C | SLC7A2-related disorder | Benign (Nov 26, 2019) | ||
8-17543321-G-A | SLC7A2-related disorder | Benign (Dec 06, 2019) | ||
8-17543326-C-T | not specified | Uncertain significance (Sep 26, 2024) | ||
8-17543329-C-T | not specified | Uncertain significance (May 02, 2023) | ||
8-17543331-G-C | not specified | Uncertain significance (Dec 08, 2023) | ||
8-17543334-G-A | not specified | Uncertain significance (May 18, 2023) | ||
8-17543352-A-G | not specified | Uncertain significance (May 26, 2024) | ||
8-17543448-A-G | not specified | Uncertain significance (Jan 03, 2024) | ||
8-17543533-G-A | not specified | Uncertain significance (Sep 26, 2024) | ||
8-17543544-G-A | not specified | Uncertain significance (Dec 21, 2023) | ||
8-17543571-G-T | not specified | Uncertain significance (Jan 17, 2024) | ||
8-17543614-G-A | not specified | Uncertain significance (Jun 02, 2023) | ||
8-17543644-A-G | not specified | Uncertain significance (Jan 04, 2024) | ||
8-17543652-G-C | SLC7A2-related disorder | Benign (Dec 11, 2019) | ||
8-17543661-G-A | not specified | Uncertain significance (May 29, 2024) | ||
8-17543707-A-G | not specified | Uncertain significance (Sep 08, 2024) | ||
8-17544468-A-G | not specified | Uncertain significance (Jul 14, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SLC7A2 | protein_coding | protein_coding | ENST00000004531 | 12 | 73486 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.34e-11 | 0.660 | 125701 | 0 | 46 | 125747 | 0.000183 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.41 | 477 | 398 | 1.20 | 0.0000219 | 4514 |
Missense in Polyphen | 142 | 140.59 | 1.01 | 1584 | ||
Synonymous | -1.96 | 195 | 163 | 1.20 | 0.0000109 | 1426 |
Loss of Function | 1.50 | 21 | 29.8 | 0.704 | 0.00000140 | 364 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000800 | 0.000794 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.000220 | 0.000217 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000143 | 0.000141 |
Middle Eastern | 0.000220 | 0.000217 |
South Asian | 0.0000654 | 0.0000653 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Functions as permease involved in the transport of the cationic amino acids (arginine, lysine and ornithine); the affinity for its substrates differs between isoforms created by alternative splicing. Isoform 1 functions as permease that mediates the transport of the cationic amino acids (arginine, lysine and ornithine), and it has much higher affinity for arginine than isoform 2. Isoform 2 functions as low-affinity, high capacity permease involved in the transport of the cationic amino acids (arginine, lysine and ornithine) (PubMed:9174363). May play a role in classical or alternative activation of macrophages via its role in arginine transport. {ECO:0000250|UniProtKB:P18581, ECO:0000269|PubMed:9174363}.;
- Pathway
- Lysine Degradation;Hyperlysinemia I, Familial;2-aminoadipic 2-oxoadipic aciduria;Pyridoxine dependency with seizures;Saccharopinuria/Hyperlysinemia II;Glutaric Aciduria Type I;Hyperlysinemia II or Saccharopinuria;Biopterin metabolism;Amino acid transport across the plasma membrane;Amino acid and oligopeptide SLC transporters;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Transport of small molecules;Lipoate metabolism;Valine, leucine and isoleucine degradation;Glycine, serine, alanine and threonine metabolism
(Consensus)
Recessive Scores
- pRec
- 0.139
Intolerance Scores
- loftool
- 0.0207
- rvis_EVS
- 0.41
- rvis_percentile_EVS
- 76.54
Haploinsufficiency Scores
- pHI
- 0.101
- hipred
- N
- hipred_score
- 0.216
- ghis
- 0.437
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.333
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc7a2
- Phenotype
- immune system phenotype;
Gene ontology
- Biological process
- nitric oxide production involved in inflammatory response;cellular amino acid metabolic process;nitric oxide biosynthetic process;amino acid transport;macrophage activation;regulation of macrophage activation;regulation of inflammatory response;L-arginine import across plasma membrane;L-ornithine transmembrane transport;L-lysine transmembrane transport
- Cellular component
- plasma membrane;integral component of plasma membrane;membrane;cell junction
- Molecular function
- L-ornithine transmembrane transporter activity;amino acid transmembrane transporter activity;basic amino acid transmembrane transporter activity;arginine transmembrane transporter activity;L-lysine transmembrane transporter activity;L-arginine transmembrane transporter activity